发明人徐明华,沈红梅,高志强. "一种达沙替尼杂质21的合成方法" [P]. 中国发明专利, 专利号 CN 111777683 A, 授权公告日 2024-11-07.
Park J H, Roberts E F, Chen K W. "Method for the Synthesis of Dasatinib Impurity 21" [P]. US Patent, US 11370809 B2, 2020-11-05.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 达沙替尼杂质21 in Pharmaceutical Formulations". J. Sep. Sci., 2013, 1941, (9), 1979-1995.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达沙替尼杂质21 as an Impurity". Anal. Methods, 2016, 601, (4), 1004-1029.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Dasatinib Impurity 21 Using HRMS and NMR". J. Chromatogr. A, 2015, 1478, (11), 1939-1951.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 达沙替尼杂质21 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2021, 722, 9813-9834.